Hanmi Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	140,401	108,274	192,278	54,980	147,329	209,225
Short-Term Investments	74,761	93,048	917.66	109,736	89,408	2,510
Trading Asset Securities	83,220	-	-	90,466	-	-
Cash & Short-Term Investments	298,382	201,322	193,195	255,183	236,736	211,734
Cash Growth	36.54%	4.21%	-24.29%	7.79%	11.81%	43.03%
Accounts Receivable	295,041	337,291	238,253	168,139	178,357	217,428
Other Receivables	9,315	4,522	517.98	9,079	1,703	5,180
Receivables	304,356	341,813	238,771	177,219	180,060	222,609
Inventory	366,767	338,532	300,926	288,814	266,185	250,189
Prepaid Expenses	2,929	2,214	1,381	865.96	4,595	10,511
Other Current Assets	10,368	10,068	12,033	8,543	6,581	8,466
Total Current Assets	982,802	893,949	746,306	730,624	694,158	703,509
Property, Plant & Equipment	789,558	786,292	822,496	860,242	917,982	957,218
Long-Term Investments	96,466	105,313	147,471	29,942	57,424	38,090
Other Intangible Assets	51,457	50,815	45,427	46,271	48,007	48,708
Long-Term Accounts Receivable	10,453	11,441	10,095	17,372	5,927	9,964
Long-Term Deferred Tax Assets	175,514	167,929	145,599	127,993	89,902	91,856
Long-Term Deferred Charges	68,379	62,462	48,709	34,774	36,580	31,461
Other Long-Term Assets	47,106	55,993	44,247	51,451	74,606	55,922
Total Assets	2,226,217	2,137,598	2,020,840	1,898,668	1,924,586	1,936,729
Accounts Payable	60,892	54,248	38,599	45,180	39,710	42,833
Accrued Expenses	10,374	3,971	13,487	16,660	14,389	11,103
Short-Term Debt	304,500	319,500	370,600	336,100	369,100	255,900
Current Portion of Long-Term Debt	13,100	13,550	31,237	145,351	80,364	144,125
Current Portion of Leases	4,690	4,436	2,916	2,325	3,043	55,141
Current Income Taxes Payable	17,621	26,459	26,855	6,088	10,677	13,463
Other Current Liabilities	226,355	183,038	199,063	153,059	159,465	126,373
Total Current Liabilities	637,531	605,202	682,759	704,763	676,748	648,938
Long-Term Debt	91,375	91,813	85,862	82,028	217,330	290,619
Long-Term Leases	4,698	4,913	6,071	7,063	8,486	10,481
Pension & Post-Retirement Benefits	5,081	4,757	-	-	-	9,026
Other Long-Term Liabilities	8,753	8,060	5,397	4,603	12,795	49,405
Total Liabilities	747,439	714,744	780,089	798,458	915,359	1,008,469
Common Stock	32,027	32,027	32,027	31,405	30,795	30,196
Additional Paid-In Capital	412,589	411,343	411,343	411,965	412,575	413,175
Retained Earnings	856,601	836,489	680,888	581,979	452,297	396,916
Treasury Stock	-40,379	-43,327	-43,327	-40,047	-36,976	-33,142
Comprehensive Income & Other	39,103	13,224	3,962	-29,860	13,174	-4,230
Total Common Equity	1,299,941	1,249,756	1,084,893	955,442	871,866	802,914
Minority Interest	178,838	173,097	155,858	144,768	137,361	125,346
Shareholders' Equity	1,478,779	1,422,853	1,240,752	1,100,211	1,009,227	928,259
Total Liabilities & Equity	2,226,217	2,137,598	2,020,840	1,898,668	1,924,586	1,936,729
Total Debt	418,363	434,211	496,687	572,867	678,323	756,267
Net Cash (Debt)	-119,981	-232,889	-303,492	-317,685	-441,586	-544,532
Net Cash Per Share	-9454.46	-18353.48	-23933.19	-25031.60	-34761.50	-42813.87
Filing Date Shares Outstanding	12.69	12.68	12.68	12.44	12.45	12.47
Total Common Shares Outstanding	12.69	12.68	12.68	12.69	12.7	12.72
Working Capital	345,271	288,748	63,548	25,861	17,410	54,571
Book Value Per Share	102474.33	98559.56	85557.93	75287.83	68636.66	63132.10
Tangible Book Value	1,248,484	1,198,941	1,039,466	909,172	823,858	754,205
Tangible Book Value Per Share	98417.99	94552.13	81975.42	71641.74	64857.35	59302.24
Land	131,846	131,846	131,866	131,788	131,280	131,256
Buildings	308,800	489,756	487,211	472,771	468,815	461,796
Machinery	270,787	891,896	875,653	838,165	837,205	792,572
Construction In Progress	50,931	37,142	13,146	14,815	6,206	69,731